Vir Biotechnology, Inc. financial data

Symbol
VIR on Nasdaq
Location
1800 Owens Street, Suite 900, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 784 % -27.9%
Debt-to-equity 32.3 % -21%
Return On Equity -50.2 % -62.4%
Return On Assets -40.8 % -56.8%
Operating Margin -3.19K % -346%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 139M shares +1.67%
Common Stock, Shares, Outstanding 139M shares +1.68%
Entity Public Float 746M USD -58.6%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 138M shares +1.63%
Weighted Average Number of Shares Outstanding, Diluted 138M shares +1.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 19M USD -75.9%
Revenue from Contract with Customer, Excluding Assessed Tax 1.21M USD -60.5%
Cost of Revenue 745K USD -21.3%
Research and Development Expense 517M USD +12.7%
Costs and Expenses 625M USD -2.79%
Operating Income (Loss) -606M USD -7.43%
Nonoperating Income (Expense) 56.5M USD -21.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -550M USD -11.7%
Income Tax Expense (Benefit) 277K USD
Net Income (Loss) Attributable to Parent -550M USD -13.9%
Earnings Per Share, Basic -4 USD/shares -12%
Earnings Per Share, Diluted -4 USD/shares -12%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 211M USD -28.9%
Marketable Securities, Current 388M USD -54.4%
Cash, Cash Equivalents, and Short-term Investments 1.19B USD -30%
Other Assets, Current 100K USD -98.7%
Assets, Current 736M USD -39%
Property, Plant and Equipment, Net 60.8M USD -7.97%
Operating Lease, Right-of-Use Asset 64.9M USD +4.16%
Intangible Assets, Net (Excluding Goodwill) 8M USD -57.7%
Goodwill 16.9M USD 0%
Assets 1.19B USD -28.6%
Accounts Payable, Current 12.2M USD +179%
Liabilities, Current 105M USD +8.91%
Deferred Income Tax Liabilities, Net 3.25M USD -82.4%
Operating Lease, Liability, Noncurrent 93.4M USD -1.7%
Other Liabilities, Noncurrent 13M USD -5.95%
Liabilities 245M USD +3.89%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.22M USD +22.9%
Retained Earnings (Accumulated Deficit) -992M USD -125%
Stockholders' Equity Attributable to Parent 947M USD -33.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 947M USD -33.9%
Liabilities and Equity 1.19B USD -28.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -78.1M USD +28.6%
Net Cash Provided by (Used in) Financing Activities 598K USD +293%
Net Cash Provided by (Used in) Investing Activities 127M USD +346%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 139M shares +1.68%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 49.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 306M USD -3.44%
Deferred Tax Assets, Valuation Allowance 453M USD +27.1%
Operating Lease, Liability 97.9M USD -21.4%
Depreciation 11.3M USD -35.1%
Payments to Acquire Property, Plant, and Equipment 1.63M USD -13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -550M USD -13.8%
Lessee, Operating Lease, Liability, to be Paid 124M USD -21%
Property, Plant and Equipment, Gross 102M USD +3.36%
Operating Lease, Liability, Current 8.83M USD -54.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.6M USD -23.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.6M USD -32.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.6M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.9M USD -23.8%
Deferred Tax Assets, Operating Loss Carryforwards 180M USD +30.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 17.2M USD +19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.3M USD -22.5%
Additional Paid in Capital 1.94B USD +3.37%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 133K USD 0%
Depreciation, Depletion and Amortization 2.87M USD -36.5%
Deferred Tax Assets, Net of Valuation Allowance 25.5M USD -37.8%
Share-based Payment Arrangement, Expense 59M USD -41.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%